0002156754-26-000001.txt : 20260929 0002156754-26-000001.hdr.sgml : 20260929 20260929123742 ACCESSION NUMBER: 0002156754-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260929 DATE AS OF CHANGE: 20260929 EFFECTIVENESS DATE: 20260929 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sialia Therapeutics, Inc. CENTRAL INDEX KEY: 0002156754 ORGANIZATION NAME: EIN: 423914705 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-599190 FILM NUMBER: 261421121 BUSINESS ADDRESS: STREET 1: 9910 IRVINE CENTER DRIVE CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 714-813-0709 MAIL ADDRESS: STREET 1: 9910 IRVINE CENTER DRIVE CITY: IRVINE STATE: CA ZIP: 92618 D 1 primary_doc.xml X0708 D LIVE 0002156754 Sialia Therapeutics, Inc. 9910 IRVINE CENTER DRIVE IRVINE CA CALIFORNIA 92618 714-813-0709 DELAWARE None None Corporation true 2026 Litain Yeh 9910 IRVINE CENTER DRIVE IRVINE CA CALIFORNIA 92618 Executive Officer Director Promoter Biotechnology Decline to Disclose 06b false 2026-09-02 false true false 0 1500000 1500000 0 false 1 0 0 0 false Sialia Therapeutics, Inc. /s/ Litain Yeh Litain Yeh CEO 2026-09-29